The global market for Rapid Adenovirus Testing was valued at US$ 980 million in the year 2024 and is projected to reach a revised size of US$ 1754 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Rapid Adenovirus Testing Market

People with compromised immunity are at increased risk of serious illness caused by adenovirus infection. Adenovirus is a very common infection and according to WHO it is estimated to be responsible for 2% to 5% of all respiratory diseases. Several laboratory tests are available for the diagnosis of adenovirus eye infections. Adenovirus diagnostic tests detect the presence of double-stranded DNA virus found in adenoid tissue. Rapid diagnosis of human adenovirus (HAdV) infection has been achieved by PCR, will aid in treatment and diagnosis of adenovirus infections.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rapid Adenovirus Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Adenovirus Testing.

The Rapid Adenovirus Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rapid Adenovirus Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rapid Adenovirus Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rapid Adenovirus Testing Market Report

Report Metric	Details
Report Name	Rapid Adenovirus Testing Market
Accounted market size in year	US$ 980 million
Forecasted market size in 2031	US$ 1754 million
CAGR	8.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Lateral Flow Immunochromatographic Assay Immunogold Assay PCR-Enzyme Hybridization Assay
Segment by Application	Hospitals Diagnostic Laboratories Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Biopanda Reagents, CTK Biotech, Creative Diagnostics, Intec PRODUCTS, Biomerieux, Accuquik, SA Scientific, F. Hoffmann-La Roche, Diasorin, Bio-Rad Laboratories, QIAGEN
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rapid Adenovirus Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rapid Adenovirus Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Rapid Adenovirus Testing Market growing?

Ans: The Rapid Adenovirus Testing Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Rapid Adenovirus Testing Market size in 2031?

Ans: The Rapid Adenovirus Testing Market size in 2031 will be US$ 1754 million.

Who are the main players in the Rapid Adenovirus Testing Market report?

Ans: The main players in the Rapid Adenovirus Testing Market are Biopanda Reagents, CTK Biotech, Creative Diagnostics, Intec PRODUCTS, Biomerieux, Accuquik, SA Scientific, F. Hoffmann-La Roche, Diasorin, Bio-Rad Laboratories, QIAGEN

What are the Application segmentation covered in the Rapid Adenovirus Testing Market report?

Ans: The Applications covered in the Rapid Adenovirus Testing Market report are Hospitals, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Rapid Adenovirus Testing Market report?

Ans: The Types covered in the Rapid Adenovirus Testing Market report are Lateral Flow Immunochromatographic Assay, Immunogold Assay, PCR-Enzyme Hybridization Assay

1 Rapid Adenovirus Testing Market Overview

1.1 Product Definition

1.2 Rapid Adenovirus Testing by Type

1.2.1 Global Rapid Adenovirus Testing Market Value Comparison by Type (2024 VS 2031)

1.2.2 Lateral Flow Immunochromatographic Assay

1.2.3 Immunogold Assay

1.2.4 PCR-Enzyme Hybridization Assay

1.3 Rapid Adenovirus Testing by Application

1.3.1 Global Rapid Adenovirus Testing Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Others

1.4 Global Rapid Adenovirus Testing Market Size Estimates and Forecasts

1.4.1 Global Rapid Adenovirus Testing Revenue 2020-2031

1.4.2 Global Rapid Adenovirus Testing Sales 2020-2031

1.4.3 Global Rapid Adenovirus Testing Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Rapid Adenovirus Testing Market Competition by Manufacturers

2.1 Global Rapid Adenovirus Testing Sales Market Share by Manufacturers (2020-2025)

2.2 Global Rapid Adenovirus Testing Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Rapid Adenovirus Testing Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Rapid Adenovirus Testing, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Rapid Adenovirus Testing, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rapid Adenovirus Testing, Product Type & Application

2.7 Global Key Manufacturers of Rapid Adenovirus Testing, Date of Enter into This Industry

2.8 Global Rapid Adenovirus Testing Market Competitive Situation and Trends

2.8.1 Global Rapid Adenovirus Testing Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Rapid Adenovirus Testing Players Market Share by Revenue

2.8.3 Global Rapid Adenovirus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Rapid Adenovirus Testing Market Scenario by Region

3.1 Global Rapid Adenovirus Testing Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Rapid Adenovirus Testing Sales by Region: 2020-2031

3.2.1 Global Rapid Adenovirus Testing Sales by Region: 2020-2025

3.2.2 Global Rapid Adenovirus Testing Sales by Region: 2026-2031

3.3 Global Rapid Adenovirus Testing Revenue by Region: 2020-2031

3.3.1 Global Rapid Adenovirus Testing Revenue by Region: 2020-2025

3.3.2 Global Rapid Adenovirus Testing Revenue by Region: 2026-2031

3.4 North America Rapid Adenovirus Testing Market Facts & Figures by Country

3.4.1 North America Rapid Adenovirus Testing Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Rapid Adenovirus Testing Sales by Country (2020-2031)

3.4.3 North America Rapid Adenovirus Testing Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Rapid Adenovirus Testing Market Facts & Figures by Country

3.5.1 Europe Rapid Adenovirus Testing Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Rapid Adenovirus Testing Sales by Country (2020-2031)

3.5.3 Europe Rapid Adenovirus Testing Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rapid Adenovirus Testing Market Facts & Figures by Region

3.6.1 Asia Pacific Rapid Adenovirus Testing Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Rapid Adenovirus Testing Sales by Region (2020-2031)

3.6.3 Asia Pacific Rapid Adenovirus Testing Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Rapid Adenovirus Testing Market Facts & Figures by Country

3.7.1 Latin America Rapid Adenovirus Testing Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Rapid Adenovirus Testing Sales by Country (2020-2031)

3.7.3 Latin America Rapid Adenovirus Testing Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rapid Adenovirus Testing Market Facts & Figures by Country

3.8.1 Middle East and Africa Rapid Adenovirus Testing Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Rapid Adenovirus Testing Sales by Country (2020-2031)

3.8.3 Middle East and Africa Rapid Adenovirus Testing Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rapid Adenovirus Testing Sales by Type (2020-2031)

4.1.1 Global Rapid Adenovirus Testing Sales by Type (2020-2025)

4.1.2 Global Rapid Adenovirus Testing Sales by Type (2026-2031)

4.1.3 Global Rapid Adenovirus Testing Sales Market Share by Type (2020-2031)

4.2 Global Rapid Adenovirus Testing Revenue by Type (2020-2031)

4.2.1 Global Rapid Adenovirus Testing Revenue by Type (2020-2025)

4.2.2 Global Rapid Adenovirus Testing Revenue by Type (2026-2031)

4.2.3 Global Rapid Adenovirus Testing Revenue Market Share by Type (2020-2031)

4.3 Global Rapid Adenovirus Testing Price by Type (2020-2031)

5 Segment by Application

5.1 Global Rapid Adenovirus Testing Sales by Application (2020-2031)

5.1.1 Global Rapid Adenovirus Testing Sales by Application (2020-2025)

5.1.2 Global Rapid Adenovirus Testing Sales by Application (2026-2031)

5.1.3 Global Rapid Adenovirus Testing Sales Market Share by Application (2020-2031)

5.2 Global Rapid Adenovirus Testing Revenue by Application (2020-2031)

5.2.1 Global Rapid Adenovirus Testing Revenue by Application (2020-2025)

5.2.2 Global Rapid Adenovirus Testing Revenue by Application (2026-2031)

5.2.3 Global Rapid Adenovirus Testing Revenue Market Share by Application (2020-2031)

5.3 Global Rapid Adenovirus Testing Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Biopanda Reagents

6.1.1 Biopanda Reagents Company Information

6.1.2 Biopanda Reagents Description and Business Overview

6.1.3 Biopanda Reagents Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Biopanda Reagents Rapid Adenovirus Testing Product Portfolio

6.1.5 Biopanda Reagents Recent Developments/Updates

6.2 CTK Biotech

6.2.1 CTK Biotech Company Information

6.2.2 CTK Biotech Description and Business Overview

6.2.3 CTK Biotech Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CTK Biotech Rapid Adenovirus Testing Product Portfolio

6.2.5 CTK Biotech Recent Developments/Updates

6.3 Creative Diagnostics

6.3.1 Creative Diagnostics Company Information

6.3.2 Creative Diagnostics Description and Business Overview

6.3.3 Creative Diagnostics Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Creative Diagnostics Rapid Adenovirus Testing Product Portfolio

6.3.5 Creative Diagnostics Recent Developments/Updates

6.4 Intec PRODUCTS

6.4.1 Intec PRODUCTS Company Information

6.4.2 Intec PRODUCTS Description and Business Overview

6.4.3 Intec PRODUCTS Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Intec PRODUCTS Rapid Adenovirus Testing Product Portfolio

6.4.5 Intec PRODUCTS Recent Developments/Updates

6.5 Biomerieux

6.5.1 Biomerieux Company Information

6.5.2 Biomerieux Description and Business Overview

6.5.3 Biomerieux Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Biomerieux Rapid Adenovirus Testing Product Portfolio

6.5.5 Biomerieux Recent Developments/Updates

6.6 Accuquik

6.6.1 Accuquik Company Information

6.6.2 Accuquik Description and Business Overview

6.6.3 Accuquik Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Accuquik Rapid Adenovirus Testing Product Portfolio

6.6.5 Accuquik Recent Developments/Updates

6.7 SA Scientific

6.7.1 SA Scientific Company Information

6.7.2 SA Scientific Description and Business Overview

6.7.3 SA Scientific Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.7.4 SA Scientific Rapid Adenovirus Testing Product Portfolio

6.7.5 SA Scientific Recent Developments/Updates

6.8 F. Hoffmann-La Roche

6.8.1 F. Hoffmann-La Roche Company Information

6.8.2 F. Hoffmann-La Roche Description and Business Overview

6.8.3 F. Hoffmann-La Roche Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.8.4 F. Hoffmann-La Roche Rapid Adenovirus Testing Product Portfolio

6.8.5 F. Hoffmann-La Roche Recent Developments/Updates

6.9 Diasorin

6.9.1 Diasorin Company Information

6.9.2 Diasorin Description and Business Overview

6.9.3 Diasorin Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Diasorin Rapid Adenovirus Testing Product Portfolio

6.9.5 Diasorin Recent Developments/Updates

6.10 Bio-Rad Laboratories

6.10.1 Bio-Rad Laboratories Company Information

6.10.2 Bio-Rad Laboratories Description and Business Overview

6.10.3 Bio-Rad Laboratories Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Bio-Rad Laboratories Rapid Adenovirus Testing Product Portfolio

6.10.5 Bio-Rad Laboratories Recent Developments/Updates

6.11 QIAGEN

6.11.1 QIAGEN Company Information

6.11.2 QIAGEN Description and Business Overview

6.11.3 QIAGEN Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2020-2025)

6.11.4 QIAGEN Rapid Adenovirus Testing Product Portfolio

6.11.5 QIAGEN Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rapid Adenovirus Testing Industry Chain Analysis

7.2 Rapid Adenovirus Testing Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rapid Adenovirus Testing Production Mode & Process Analysis

7.4 Rapid Adenovirus Testing Sales and Marketing

7.4.1 Rapid Adenovirus Testing Sales Channels

7.4.2 Rapid Adenovirus Testing Distributors

7.5 Rapid Adenovirus Testing Customer Analysis

8 Rapid Adenovirus Testing Market Dynamics

8.1 Rapid Adenovirus Testing Industry Trends

8.2 Rapid Adenovirus Testing Market Drivers

8.3 Rapid Adenovirus Testing Market Challenges

8.4 Rapid Adenovirus Testing Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rapid Adenovirus Testing Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Rapid Adenovirus Testing Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Rapid Adenovirus Testing Market Competitive Situation by Manufacturers in 2024

Table 4. Global Rapid Adenovirus Testing Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Rapid Adenovirus Testing Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Rapid Adenovirus Testing Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Rapid Adenovirus Testing Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Rapid Adenovirus Testing Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Rapid Adenovirus Testing, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Rapid Adenovirus Testing, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rapid Adenovirus Testing, Product Type & Application

Table 12. Global Key Manufacturers of Rapid Adenovirus Testing, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rapid Adenovirus Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Adenovirus Testing as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rapid Adenovirus Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Rapid Adenovirus Testing Sales by Region (2020-2025) & (K Units)

Table 18. Global Rapid Adenovirus Testing Sales Market Share by Region (2020-2025)

Table 19. Global Rapid Adenovirus Testing Sales by Region (2026-2031) & (K Units)

Table 20. Global Rapid Adenovirus Testing Sales Market Share by Region (2026-2031)

Table 21. Global Rapid Adenovirus Testing Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Rapid Adenovirus Testing Revenue Market Share by Region (2020-2025)

Table 23. Global Rapid Adenovirus Testing Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Rapid Adenovirus Testing Revenue Market Share by Region (2026-2031)

Table 25. North America Rapid Adenovirus Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Rapid Adenovirus Testing Sales by Country (2020-2025) & (K Units)

Table 27. North America Rapid Adenovirus Testing Sales by Country (2026-2031) & (K Units)

Table 28. North America Rapid Adenovirus Testing Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Rapid Adenovirus Testing Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Rapid Adenovirus Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Rapid Adenovirus Testing Sales by Country (2020-2025) & (K Units)

Table 32. Europe Rapid Adenovirus Testing Sales by Country (2026-2031) & (K Units)

Table 33. Europe Rapid Adenovirus Testing Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Rapid Adenovirus Testing Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Rapid Adenovirus Testing Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Rapid Adenovirus Testing Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Rapid Adenovirus Testing Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Rapid Adenovirus Testing Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Rapid Adenovirus Testing Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Rapid Adenovirus Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Rapid Adenovirus Testing Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Rapid Adenovirus Testing Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Rapid Adenovirus Testing Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Rapid Adenovirus Testing Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Rapid Adenovirus Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Rapid Adenovirus Testing Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Rapid Adenovirus Testing Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Rapid Adenovirus Testing Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Rapid Adenovirus Testing Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Rapid Adenovirus Testing Sales (K Units) by Type (2020-2025)

Table 51. Global Rapid Adenovirus Testing Sales (K Units) by Type (2026-2031)

Table 52. Global Rapid Adenovirus Testing Sales Market Share by Type (2020-2025)

Table 53. Global Rapid Adenovirus Testing Sales Market Share by Type (2026-2031)

Table 54. Global Rapid Adenovirus Testing Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Rapid Adenovirus Testing Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Rapid Adenovirus Testing Revenue Market Share by Type (2020-2025)

Table 57. Global Rapid Adenovirus Testing Revenue Market Share by Type (2026-2031)

Table 58. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2020-2025)

Table 59. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2026-2031)

Table 60. Global Rapid Adenovirus Testing Sales (K Units) by Application (2020-2025)

Table 61. Global Rapid Adenovirus Testing Sales (K Units) by Application (2026-2031)

Table 62. Global Rapid Adenovirus Testing Sales Market Share by Application (2020-2025)

Table 63. Global Rapid Adenovirus Testing Sales Market Share by Application (2026-2031)

Table 64. Global Rapid Adenovirus Testing Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Rapid Adenovirus Testing Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Rapid Adenovirus Testing Revenue Market Share by Application (2020-2025)

Table 67. Global Rapid Adenovirus Testing Revenue Market Share by Application (2026-2031)

Table 68. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2020-2025)

Table 69. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2026-2031)

Table 70. Biopanda Reagents Company Information

Table 71. Biopanda Reagents Description and Business Overview

Table 72. Biopanda Reagents Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Biopanda Reagents Rapid Adenovirus Testing Product

Table 74. Biopanda Reagents Recent Developments/Updates

Table 75. CTK Biotech Company Information

Table 76. CTK Biotech Description and Business Overview

Table 77. CTK Biotech Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. CTK Biotech Rapid Adenovirus Testing Product

Table 79. CTK Biotech Recent Developments/Updates

Table 80. Creative Diagnostics Company Information

Table 81. Creative Diagnostics Description and Business Overview

Table 82. Creative Diagnostics Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Creative Diagnostics Rapid Adenovirus Testing Product

Table 84. Creative Diagnostics Recent Developments/Updates

Table 85. Intec PRODUCTS Company Information

Table 86. Intec PRODUCTS Description and Business Overview

Table 87. Intec PRODUCTS Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Intec PRODUCTS Rapid Adenovirus Testing Product

Table 89. Intec PRODUCTS Recent Developments/Updates

Table 90. Biomerieux Company Information

Table 91. Biomerieux Description and Business Overview

Table 92. Biomerieux Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Biomerieux Rapid Adenovirus Testing Product

Table 94. Biomerieux Recent Developments/Updates

Table 95. Accuquik Company Information

Table 96. Accuquik Description and Business Overview

Table 97. Accuquik Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Accuquik Rapid Adenovirus Testing Product

Table 99. Accuquik Recent Developments/Updates

Table 100. SA Scientific Company Information

Table 101. SA Scientific Description and Business Overview

Table 102. SA Scientific Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. SA Scientific Rapid Adenovirus Testing Product

Table 104. SA Scientific Recent Developments/Updates

Table 105. F. Hoffmann-La Roche Company Information

Table 106. F. Hoffmann-La Roche Description and Business Overview

Table 107. F. Hoffmann-La Roche Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. F. Hoffmann-La Roche Rapid Adenovirus Testing Product

Table 109. F. Hoffmann-La Roche Recent Developments/Updates

Table 110. Diasorin Company Information

Table 111. Diasorin Description and Business Overview

Table 112. Diasorin Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Diasorin Rapid Adenovirus Testing Product

Table 114. Diasorin Recent Developments/Updates

Table 115. Bio-Rad Laboratories Company Information

Table 116. Bio-Rad Laboratories Description and Business Overview

Table 117. Bio-Rad Laboratories Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Bio-Rad Laboratories Rapid Adenovirus Testing Product

Table 119. Bio-Rad Laboratories Recent Developments/Updates

Table 120. QIAGEN Company Information

Table 121. QIAGEN Description and Business Overview

Table 122. QIAGEN Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. QIAGEN Rapid Adenovirus Testing Product

Table 124. QIAGEN Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Rapid Adenovirus Testing Distributors List

Table 128. Rapid Adenovirus Testing Customers List

Table 129. Rapid Adenovirus Testing Market Trends

Table 130. Rapid Adenovirus Testing Market Drivers

Table 131. Rapid Adenovirus Testing Market Challenges

Table 132. Rapid Adenovirus Testing Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Rapid Adenovirus Testing

Figure 2. Global Rapid Adenovirus Testing Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rapid Adenovirus Testing Market Share by Type: 2024 & 2031

Figure 4. Lateral Flow Immunochromatographic Assay Product Picture

Figure 5. Immunogold Assay Product Picture

Figure 6. PCR-Enzyme Hybridization Assay Product Picture

Figure 7. Global Rapid Adenovirus Testing Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Rapid Adenovirus Testing Market Share by Application: 2024 & 2031

Figure 9. Hospitals

Figure 10. Diagnostic Laboratories

Figure 11. Others

Figure 12. Global Rapid Adenovirus Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Rapid Adenovirus Testing Market Size (2020-2031) & (US$ Million)

Figure 14. Global Rapid Adenovirus Testing Sales (2020-2031) & (K Units)

Figure 15. Global Rapid Adenovirus Testing Average Price (US$/Unit) & (2020-2031)

Figure 16. Rapid Adenovirus Testing Report Years Considered

Figure 17. Rapid Adenovirus Testing Sales Share by Manufacturers in 2024

Figure 18. Global Rapid Adenovirus Testing Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Rapid Adenovirus Testing Players: Market Share by Revenue in Rapid Adenovirus Testing in 2024

Figure 20. Rapid Adenovirus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Rapid Adenovirus Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Rapid Adenovirus Testing Sales Market Share by Country (2020-2031)

Figure 23. North America Rapid Adenovirus Testing Revenue Market Share by Country (2020-2031)

Figure 24. United States Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Rapid Adenovirus Testing Sales Market Share by Country (2020-2031)

Figure 27. Europe Rapid Adenovirus Testing Revenue Market Share by Country (2020-2031)

Figure 28. Germany Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Rapid Adenovirus Testing Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Rapid Adenovirus Testing Revenue Market Share by Region (2020-2031)

Figure 35. China Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Rapid Adenovirus Testing Sales Market Share by Country (2020-2031)

Figure 45. Latin America Rapid Adenovirus Testing Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Rapid Adenovirus Testing Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Rapid Adenovirus Testing Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Rapid Adenovirus Testing Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Rapid Adenovirus Testing by Type (2020-2031)

Figure 55. Global Revenue Market Share of Rapid Adenovirus Testing by Type (2020-2031)

Figure 56. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Rapid Adenovirus Testing by Application (2020-2031)

Figure 58. Global Revenue Market Share of Rapid Adenovirus Testing by Application (2020-2031)

Figure 59. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2020-2031)

Figure 60. Rapid Adenovirus Testing Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions